SUGAR LAND--August 23, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--By the end of the third quarter of 2016, the Pharmaceutical-Biotech industry is expected to complete construction on a total of 268 North American capital and MRO (maintenance, repair and operations) projects. A recent survey of reported projects in Industrial Info's Pharmaceutical-Biotech Online Database reveals that the projects represent a total investment value (TIV) of $5.92 billion.

Within this article: Lists three pharmaceutical projects that Industrial Info is tracking Additional companies: Gilead Sciences (NASDAQ:GILD)